New Insurance Strategy Pits Patients Against Their Pocketbooks
Which would you choose – $500 or the medication that effectively manages your condition? It’s a tough choice, but one that patients across the country now face.
What Biosimilars Mean for Cancer Care
Biosimilars offer more cancer treatment options at potentially lower prices. So why aren’t they more accessible?
Getting to the Root of Obesity
From fat shaming to self-love, America’s debate over weight often overlooks a critical point. Obesity is a dangerous and chronic health condition that drives both cardiovascular disease and Type 2 diabetes. So explains, “Root Cause,” a joint policy paper released by the Diabetes Policy Collaborative, the Alliance for Patient Access and the Partnership to Advance […]
Making Telemedicine Work for Underserved Communities
The very patients who stand to benefit most from telemedicine aren’t, recent studies suggest. Now, gaps in access are calling for creative solutions.
From Mom to Baby: Antibodies and Infant Health
Everyone knows children inherit some things from their parents: their blue eyes, their curly hair, or perhaps their love of the outdoors. Moms take prenatal vitamins and get maternal vaccines like Tdap to transfer health benefits and good antibodies to their unborn babies.
Giving Patients a Say on Opioid Risks
Victory over pain is the greatest gift an anesthesiologist like me can offer his patients. I discovered that firsthand when I switched from general surgery to anesthesiology 20 years ago.
New Obesity Drug Wins FDA Approval
A staggering 42% of adults in America are obese. Without serious relief, that number will be one in two by the end of this decade. But help is on the way.
I Was a Telehealth Skeptic
Even the biggest skeptic can be converted into a ferocious advocate. I know from first-hand experience.
The Widening Mental Health Gap
Most Americans are slowly moving past the pandemic, but the mental strain of the last year may linger until they can access treatment. Too bad that’s easier said than done.
First-in-Class Alzheimer’s Drug Earns Federal Approval
For Alzheimer’s patients, the long wait is over.
